CAT and neoplasm: In another study performed by Hei and collaborators, catalase was also incorporated in liposomes, to overcome tumor hypoxia, presenting at their surface a programmed death ligand 1 monoclonal antibody to enhance immunotherapeutic effects towards melanoma.